NOF Corp. (TYO:4403) plans to invest more than 10 billion yen ($87.49 million) by fiscal 2025 in its drug delivery…...
Please subscribe to read the full story.
drug delivery systems
NOF Moves to Boost Production of DDS Materials for Biopharmaceuticals
NOF Corp. (TYO:4403) is planning to increase its production capacity for activated polyethylene glycol (PEG), a material that serves to…...
Please subscribe to read the full story.
